Basic Information
FASENRA
0310-1730
Regulatory Information
0310-1730
BLA761070
C73585
February 23, 2021
USA
These highlights do not include all the information needed to use FASENRA safely and effectively. See full prescribing information for FASENRA.FASENRA (benralizumab) injection, for subcutaneous useInitial U.S. Approval: 2017
HUMAN PRESCRIPTION DRUG LABEL
20
Company Information
054743190
Active Ingredients
HISTIDINE MONOHYDROCHLORIDE
Quantity: 2.3 mg in 1 mL
Code: 1D5Q932XM6
Class Code: IACT
WATER
Quantity: 910 mg in 1 mL
Code: 059QF0KO0R
Class Code: IACT
POLYSORBATE 20
Quantity: 0.06 mg in 1 mL
Code: 7T1F30V5YH
Class Code: IACT
HISTIDINE
Quantity: 1.4 mg in 1 mL
Code: 4QD397987E
Class Code: IACT
TREHALOSE DIHYDRATE
Quantity: 95 mg in 1 mL
Code: 7YIN7J07X4
Class Code: IACT
Active Moieties
BENRALIZUMAB
Code: 71492GE1FX